Skip to content

GILEAD SCIENCES, INC.: RCUS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of GILEAD SCIENCES, INC. on RCUS, newest first. How the timeline and the estimate are built.

GILEAD SCIENCES, INC. held 31,424,760 RCUS shares at 2026-09-30 per its 13F-HR filed 2026-11-06.

the latest 13F is the newest step

  1. period ended2026-09-30
    13F 31,424,760 shares
    Change vs previous 13F 0 shares

    55.45% of the 13F portfolio, value $811,701,551.

    13F-HR 0001123292-26-001479 filed by GILEAD SCIENCES, INC.
    Accepted , ingested

  2. period ended2026-06-30
    13F 31,424,760 shares
    Change vs previous 13F 0 shares

    58.76% of the 13F portfolio, value $968,825,351.

    13F-HR 0001123292-26-001034 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2026-03-31
    13F 31,424,760 shares
    Change vs previous 13F 0 shares

    32.05% of the 13F portfolio, value $678,774,816.

    13F-HR 0001123292-26-000642 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-12-31
    13F 31,424,760 shares
    Change vs previous 13F 0 shares

    38.69% of the 13F portfolio, value $748,852,031.

    13F-HR 0001123292-26-000164 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-09-30
    13F 31,424,760 shares
    Change vs previous 13F 0 shares

    23.86% of the 13F portfolio, value $427,376,736.

    13F-HR 0001123292-25-000642 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-06-30
    13F 31,424,760 shares
    Change vs previous 13F 0 shares

    19.98% of the 13F portfolio, value $255,797,546.

    13F-HR 0001123292-25-000364 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2025-03-31
    13F 31,424,760 shares
    Change vs previous 13F +1,363,636 shares

    20.88% of the 13F portfolio, value $246,684,366.

    13F-HR 0001123292-25-000217 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-12-31
    13F 30,061,124 shares
    Change vs previous 13F not available

    28.86% of the 13F portfolio, value $447,610,136.

    13F-HR 0001123292-25-000079 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).